Clorox (NYSE:CLX) Price Target Raised to $171.00

Clorox (NYSE:CLX - Get Free Report) had its target price hoisted by stock analysts at JPMorgan Chase & Co. from $167.00 to $171.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s price target suggests a potential upside of 6.54% from the company's current price.

Other research analysts have also issued reports about the stock. StockNews.com lowered shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Jefferies Financial Group upgraded shares of Clorox from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. DA Davidson boosted their price objective on shares of Clorox from $153.00 to $171.00 and gave the stock a "neutral" rating in a research note on Monday, November 4th. TD Cowen upgraded shares of Clorox from a "sell" rating to a "hold" rating and boosted their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Finally, Evercore ISI decreased their price target on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research note on Monday, October 14th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, Clorox has an average rating of "Hold" and a consensus price target of $157.23.

Clorox Stock Up 1.4 %

NYSE:CLX traded up $2.20 on Thursday, hitting $160.50. 871,212 shares of the company's stock were exchanged, compared to its average volume of 954,132. The firm has a 50-day moving average price of $164.40 and a 200-day moving average price of $156.17. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. Clorox has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a market cap of $19.87 billion, a P/E ratio of 55.92, a price-to-earnings-growth ratio of 2.90 and a beta of 0.42.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.64 billion. During the same period in the previous year, the firm posted $0.49 EPS. The company's revenue for the quarter was up 27.0% on a year-over-year basis. As a group, analysts expect that Clorox will post 6.87 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in CLX. Catalyst Capital Advisors LLC bought a new stake in shares of Clorox during the 3rd quarter worth approximately $54,000. AQR Capital Management LLC lifted its holdings in shares of Clorox by 8.6% during the 2nd quarter. AQR Capital Management LLC now owns 287,277 shares of the company's stock worth $39,121,000 after acquiring an additional 22,676 shares during the period. Los Angeles Capital Management LLC lifted its holdings in shares of Clorox by 5.6% during the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company's stock worth $31,266,000 after acquiring an additional 10,149 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its holdings in shares of Clorox by 60.5% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 23,769 shares of the company's stock worth $3,244,000 after acquiring an additional 8,957 shares during the period. Finally, Canada Pension Plan Investment Board lifted its holdings in shares of Clorox by 1.6% during the 2nd quarter. Canada Pension Plan Investment Board now owns 353,394 shares of the company's stock worth $48,228,000 after acquiring an additional 5,500 shares during the period. Institutional investors and hedge funds own 78.53% of the company's stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.